What is the maximum recommended dose of Rupall (rupatadine) for adults, adolescents, and children of different age groups?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rupall Maximum Dosing

The maximum recommended dose of Rupall (rupatadine) is 20 mg once daily for adults and adolescents aged 12 years and older, while children aged 6-11 years should receive a maximum of 10 mg once daily.

Age-Specific Maximum Dosing

Adults and Adolescents (≥12 years)

  • Standard dose: 10 mg once daily
  • Maximum dose: 20 mg once daily 1, 2
  • The 20 mg dose can be used when 10 mg provides insufficient symptom control, particularly in chronic spontaneous urticaria 1, 2

Children (6-11 years)

  • Standard and maximum dose: 10 mg once daily (using 1 mg/ml oral solution) 3, 4
  • This dosing has been validated in large multicenter trials for persistent allergic rhinitis 3

Children (2-5 years)

  • Dose: 2.5-5 mg once daily 4
  • Limited data available; use with caution in this age group

Not Recommended

  • Children under 2 years of age (insufficient safety and efficacy data)

Clinical Context for Up-Dosing

For chronic spontaneous urticaria specifically, up-dosing from 10 mg to 20 mg once daily is well-established when patients fail to achieve adequate control at the standard dose 1, 2. The Japanese clinical trial demonstrated that both 10 mg and 20 mg doses were significantly more effective than placebo, with no dose-related increase in adverse events 1. Long-term safety data over 52 weeks confirms that 20 mg daily can be used safely when needed 2.

Safety Profile at Maximum Doses

The most common adverse effect is somnolence (reported in approximately 14% of patients), with no serious adverse events documented at either 10 mg or 20 mg doses 1, 2. Importantly, there is no dose-dependent increase in adverse effects when escalating from 10 mg to 20 mg 1, 5. No QTc prolongation or clinically significant laboratory abnormalities have been reported 3.

Important Caveats

  • Do not exceed 20 mg daily in adults/adolescents or 10 mg daily in children aged 6-11 years, as higher doses have not been studied
  • Rupatadine has Grade A recommendation for up-dosing in chronic urticaria based on high-quality evidence 5
  • The oral solution formulation (1 mg/ml) is specifically designed for pediatric use 3, 4
  • Rupatadine is one of only two antihistamines (along with cetirizine) with documented safety and efficacy for up-dosing in children 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.